Phoenix, Arizona-based Avella Specialty Pharmacy, acquired by UnitedHealth Group Inc.’s Irvine, California-based OptumRX subsidiary in 2018, has announced that they will be closing two sites in Houston, Texas which will result in the loss of 161 positions. A company spokesperson noted that the two facilities “do not align to our overall business objectives at this time.” Avella compounds and distributes specialty drugs, which are often high-cost and are used to treat complex conditions. Avella’s purchase from Riordan, Lewis & Haden, a private equity firm, was kept private. It is believed that this acquisition will position OptumRX’s specialty unit BriovaRx as the third largest specialty pharmacy in the United States.
Change is coming. There will always be a tomorrow, no matter how much you may try to ignore it. There are no guarantees in life, or promises for a bright future. Just because something bad hasn't happened yet, doesn't mean it won't. It can happen to anyone, anytime, anywhere ... are you now wondering, Am I Next?